Biomimetic Recognition of SARS-CoV-2 Receptor-Binding Domain N-Glycans by an Antiviral Synthetic Receptor

被引:0
|
作者
Santambrogio, Carlo [1 ]
Toccafondi, Mirco [2 ]
Donnici, Lorena [2 ]
Pesce, Elisa [2 ,3 ]
De Francesco, Raffaele [2 ,4 ]
Grifantini, Renata [2 ]
Ponzini, Erika [5 ,6 ]
Milanesi, Francesco [7 ]
Fragai, Marco [8 ]
Nativi, Cristina [7 ]
Roelens, Stefano [7 ,9 ]
Grandori, Rita [1 ,10 ]
Francesconi, Oscar [7 ]
机构
[1] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, I-20126 Milan, Italy
[2] Ist Nazl Genet Mol INGM Romeo & Enrica Invernizzi, I-20122 Milan, Italy
[3] Univ Milan, Dipartimento Sci Clin & Comun, Dipartimento Eccellenza 2023 2027, Milan, Italy
[4] Univ Milan, Dipartimento Sci Farmacolog & Biomolecolari, Milan, Italy
[5] Univ Milano Bicocca, Dipartimento Sci Mat, I-20125 Milan, Italy
[6] Univ Milano Bicocca, Opt & Optometry Res Ctr COMiB, I-20125 Milan, Italy
[7] Univ Firenze, Dipartimento Chim Ugo Schiff DICUS, Florence, Italy
[8] Univ Firenze, Ctr Risonanze Magnet CERM, Florence, Italy
[9] Consorzio Interuniv Nazl Sci & Tecnol Mat INSTM, Florence, Italy
[10] Forschungszentrum Juelich, Inst Adv Simulat, D-52428 Julich, Germany
关键词
enveloped viruses; N-glycans; mannose recognition; synthetic receptors; native mass spectroscopy; TRIPODAL RECEPTORS; CAGE RECEPTOR; DC-SIGN; GLYCOSYLATION; HIV-1; SPIKE; GLYCOPROTEINS; PROTEINS; POTENT; VIRUS;
D O I
10.1002/cbic.202500106
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recognition of glycans by simple synthetic receptors is a key issue in supramolecular chemistry, endowed with relevant implications in glycobiology and medicine. In this context, glycoproteins featuring N-glycans represent an important biological target, because they are often exploited by enveloped viruses in adhesion and infection processes. However, a direct evidence for their recognition by a synthetic receptor targeting N-glycans is still missing in the literature. Using a combination of glycoengineering and mass spectrometry techniques, we present here the direct evidence of biomimetic recognition of complex-type N-glycans exposed on the receptor-binding domain (RBD) of the wild-type spike protein of SARS-CoV-2 by a biologically active, synthetic receptor.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2
    Sakib, Md Minhas Hossain
    Nishat, Aktiya Anjum
    Islam, Mohammad Tarequl
    Raihan Uddin, Mohammad Abu
    Iqbal, Md Shahriar
    Bin Hossen, Farhan Fuad
    Ahmed, Mohammad Imran
    Bashir, Md Samiul
    Hossain, Takbir
    Tohura, Umma Sumia
    Saif, Saiful Islam
    Jui, Nabilah Rahman
    Alam, Mosharaf
    Islam, Md Aminul
    Hasan, Md Mehadi
    Sufian, Md Abu
    Ali, Md Ackas
    Islam, Rajib
    Hossain, Mohammed Akhter
    Halim, Mohammad A.
    Computers in Biology and Medicine, 2021, 136
  • [22] Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2
    Sakib, Md Minhas Hossain
    Nishat, Aktiya Anjum
    Islam, Mohammad Tarequl
    Uddin, Mohammad Abu Raihan
    Iqbal, Md Shahriar
    Bin Hossen, Farhan Fuad
    Ahmed, Mohammad Imran
    Bashir, Md Samiul
    Hossain, Takbir
    Tohura, Umma Sumia
    Saif, Saiful Islam
    Jui, Nabilah Rahman
    Alam, Mosharaf
    Islam, Md Aminul
    Hasan, Md Mehadi
    Abu Sufian, Md
    Ali, Md Ackas
    Islam, Rajib
    Hossain, Mohammed Akhter
    Halim, Mohammad A.
    COMPUTERS IN BIOLOGY AND MEDICINE, 2021, 136
  • [23] Peptide Inhibitors of the Interaction of the SARS-CoV-2 Receptor-Binding Domain with the ACE2 Cell Receptor
    Bibilashvili, R. Sh.
    Sidorova, M. V.
    Dudkina, U. S.
    Palkeeva, M. E.
    Molokoedov, A. S.
    Kozlovskaya, L. I.
    Egorov, A. M.
    Ishmukhametov, A. A.
    Parfyonova, E. V.
    BIOCHEMISTRY MOSCOW-SUPPLEMENT SERIES B-BIOMEDICAL CHEMISTRY, 2021, 15 (04) : 274 - 280
  • [24] Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain
    Wheatley, Adam K.
    Pymm, Phillip
    Esterbauer, Robyn
    Dietrich, Melanie H.
    Lee, Wen Shi
    Drew, Damien
    Kelly, Hannah G.
    Chan, Li-Jin
    Mordant, Francesca L.
    Black, Katrina A.
    Adair, Amy
    Tan, Hyon-Xhi
    Juno, Jennifer A.
    Wragg, Kathleen M.
    Amarasena, Thakshila
    Lopez, Ester
    Selva, Kevin J.
    Haycroft, Ebene R.
    Cooney, James P.
    Venugopal, Hariprasad
    Tan, Li Lynn
    Neill, Matthew T. O.
    Allison, Cody C.
    Cromer, Deborah
    Davenport, Miles P.
    Bowen, Richard A.
    Chung, Amy W.
    Pellegrini, Marc
    Liddament, Mark T.
    Glukhova, Alisa
    Subbarao, Kanta
    Kent, Stephen J.
    Tham, Wai-Hong
    CELL REPORTS, 2021, 37 (02):
  • [25] Peptide Inhibitors of the Interaction of the SARS-CoV-2 Receptor-Binding Domain with the ACE2 Cell Receptor
    R. Sh. Bibilashvili
    M. V. Sidorova
    U. S. Dudkina
    M. E. Palkeeva
    A. S. Molokoedov
    L. I. Kozlovskaya
    A. M. Egorov
    A. A. Ishmukhametov
    E.V. Parfyonova
    Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 2021, 15 : 274 - 280
  • [26] Identification of an Optimized Receptor-Binding Domain Subunit Vaccine against SARS-CoV-2
    Yu, Hong
    Worrall, Liam J.
    Berger, Thorsten
    Petric, Martin
    Lin, Bryan H.
    Vuckovic, Marija
    Robb, Craig S.
    Le, Quan
    Kenward, Calem
    Dai, Chuanbin
    Wakeham, Andrew
    Liu, Shaofeng
    Snow, Bryan
    Tobin, Chantal
    Budylowski, Patrick
    Guvenc, Furkan
    You-Ten, Annick
    Haight, Jillian
    Silvester, Jennifer
    Singh, Rashim Pal
    Ahn, Sang Kyun
    Sultana, Azmiri
    Poon, Betty
    Lam, Jessica
    Christie-Holmes, Natasha
    Ostrowski, Mario
    Gray-Owen, Scott D.
    Kubli, Shawn
    Mak, Tak
    Strynadka, Natalie C. J.
    Brunham, Robert C.
    JOURNAL OF IMMUNOLOGY, 2023, 211 (06): : 981 - 993
  • [27] Insights on the mutational landscape of the SARS-CoV-2 Omicron variant receptor-binding domain
    Miller, Nathaniel L.
    Clark, Thomas
    Raman, Rahul
    Sasisekharan, Ram
    CELL REPORTS MEDICINE, 2022, 3 (02)
  • [28] Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine
    Deliyannis, Georgia
    Gherardin, Nicholas A.
    Wong, Chinn Yi
    Grimley, Samantha L.
    Cooney, James P.
    Redmond, Samuel J.
    Ellenberg, Paula
    Davidson, Kathryn C.
    Mordant, Francesca L.
    Smith, Tim
    Gillard, Marianne
    Lopez, Ester
    McAuley, Julie
    Tan, Chee Wah
    Wang, Jing J.
    Zeng, Weiguang
    Littlejohn, Mason
    Zhou, Runhong
    Chan, Jasper Fuk-Woo
    Chen, Zhi-wei
    Hartwig, Airn E.
    Bowen, Richard
    Mackenzie, Jason M.
    Vincan, Elizabeth
    Torresi, Joseph
    Kedzierska, Katherine
    Pouton, Colin W.
    Gordon, Tom P.
    Wang, Lin-fa
    Kent, Stephen J.
    Wheatley, Adam K.
    Lewin, Sharon R.
    Subbarao, Kanta
    Chung, Amy W.
    Pellegrini, Marc
    Munro, Trent
    Nolan, Terry
    Rockman, Steven
    Jackson, David C.
    Purcell, Damian F. J.
    Godfrey, Dale I.
    EBIOMEDICINE, 2023, 92
  • [29] An antibody-escape estimator for mutations to the SARS-CoV-2 receptor-binding domain
    Greaney, Allison J.
    Starr, Tyler N.
    Bloom, Jesse D.
    VIRUS EVOLUTION, 2022, 8 (01)
  • [30] Small Molecules Targeting SARS-CoV-2 Spike Glycoprotein Receptor-Binding Domain
    Rodriguez, Yoel
    Cardoze, Scarlet Martinez
    Obineche, Onyinyechi W.
    Melo, Claudia
    Persaud, Ashanna
    Romero, Jose A. Fernandez
    ACS OMEGA, 2022, 7 (33): : 28779 - 28789